• Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

    Not recruiting

    3 1 1
    Investigated diseases:
    Czechia Finland Hungary Italy Poland Slovakia +1
  • Study of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Poland
  • Study of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)

    Not recruiting

    3 1 1
    Investigated diseases:
    France Germany Greece Italy Poland Romania
  • Study of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Greece Poland Slovakia Spain
  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +9
  • Comparison of rosuvastatin/ezetimibe tablets versus capsules in healthy volunteers: A single-dose bioequivalence study of 20 mg/10 mg formulations

    Not recruiting

    1 1 1 1
    Spain
  • Long-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Czechia France Germany Italy The Netherlands Portugal +1
  • Study of cytisinicline and moxifloxacin effects on heart electrical activity in healthy smokers with nicotine addiction

    Not recruiting

    1 1 1
    Investigated diseases:
    Portugal
  • Comparison of Oxazepam 50 mg orodispersible tablets and Oxazepam 50 mg standard tablets in healthy volunteers to test if they work the same way in the body

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal
  • Study of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Croatia France Germany Greece Hungary +4

powered by